Is TB-500 FDA-approved?

No. TB-500 isn't FDA-approved: Drugs@FDA lists no application with TB-500 as an active ingredient.

Checked 23 Oct 2026. The sources are below.

TB-500

Also: Thymosin Beta-4 Fragment (Ac-LKKTETQ), TB500, N-acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln

Status label in the Peptimes Library
Not FDA-Approved
Routes in Peptimes
SubcutaneousIntramuscular
Updated
2 Nov 2026

US regulatory status

  • FDA status

    Not FDA-Approved. Drugs@FDA lists no application with TB-500 as an active ingredient.

    Source: Drugs@FDA, checked 23 Oct 2026

Compounding status in the US

The Peptimes Library shows this compounding note:

Removed from FDA’s Category 2 safety list in April 2026 after its nomination was withdrawn; it is not on any FDA list that allows compounding, and FDA has not decided after its July 2026 advisory committee review. On 30 Oct 2026, HHS published a draft, non-binding policy: until FDA decides through rulemaking, it does not intend to act against licensed pharmacies and doctors that compound TB-500 acetate for injection under the skin or into muscle, on a patient-specific prescription and only under the policy’s conditions. This is not FDA approval, and compounded drugs are not FDA-approved.

Sources: FDA, Certain bulk drug substances for use in compounding that may present significant safety risks (content current as of 22 Apr 2026); FDA, July 23–24, 2026 Pharmacy Compounding Advisory Committee meeting; Federal Register notice 2026-22192; HHS’s policy document, all checked 2 Nov 2026.

How to track it in Peptimes

The Library has two entries for TB-500, and both show the status label “Not FDA-Approved”. “TB-500” can be logged as subcutaneous or intramuscular. “TB4 Fragment (17-23)” is a separate entry, and it is subcutaneous only. Thymosin beta-4 itself has separate entries. Add the entry that matches your own records in My Protocols, and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose.

  • Logging: the amount you took, the route and how you feel.
  • Injection sites: each dose records the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell TB-500 or any other compound.

More sources

  • FDA, Global Substance Registration System, TB-500, checked 23 Oct 2026: its sequence of seven amino acids, and the names TB500 and N-acetyl-Leu-Lys-Lys-Thr-Glu-Thr-Gln. “Thymosin Beta-4 Fragment (Ac-LKKTETQ)” is the name the Peptimes Library gives it.

Coming soon to the App Store

Coming soon to Google Play

See planned pricing